Pharmacy-based PrEP emerges as key in Kenya's HIV fight

PrEP is an antiretroviral medication that prevents HIV infection when taken consistently by individuals at substantial risk. [Courtesy]

New data showing a rise in fresh cases of HIV infection has renewed focus on prevention gaps and the urgent need to expand access to HIV pre-exposure prophylaxis (PrEP) as Kenya works towards eliminating infections by 2030.

Health officials and stakeholders are now pushing for greater involvement of community pharmacies as access points for HIV prevention services, including PrEP, amid persistent barriers to facility-based care.